Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.15
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 333,263
  • Market Cap: £1.76m
  • RiskGrade: 504

Physiomics wins new contract with French pharma company

By Iain Gilbert

Date: Friday 08 Apr 2022

LONDON (ShareCast) - (Sharecast News) - Oncology drug developer Physiomics has been awarded a contract by new client, the Servier Group, an international pharmaceutical company based in France.
Physiomics said on Friday that it will provide specialist mathematical modelling services to Servier, which has a particular focus on immunotherapies and monoclonal antibodies for difficult to treat diseases, using its Virtual Tumour software platform to model and simulate the effect of a number of immuno-oncology combinations involving Servier drugs in development in pre-clinical and clinical settings.

The AIM-listed firm anticipates that the project will be completed over the course of the next seven to eight months.

Financial terms of the deal were not disclosed.

Chief executive Dr Jim Millen said : "We are delighted to have been selected by Servier, one of France's leading pharmaceutical companies with a truly global outlook as its partner for this modelling and simulation project focused on pre-clinical and translational modelling of a novel immuno-oncology agent in development."

As of 1030 BST, Physiomics shares were down 3.96% at 4.35p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Physiomics Market Data

Currency UK Pounds
Share Price 1.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.15
52 Week Low 0.95
Volume 333,263
Shares Issued 135.47m
Market Cap £1.76m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.03% below the market average31.03% below the market average31.03% below the market average31.03% below the market average31.03% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Price Trend
83.54% below the market average83.54% below the market average83.54% below the market average83.54% below the market average83.54% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average
Income Not Available
Growth
59.43% below the market average59.43% below the market average59.43% below the market average59.43% below the market average59.43% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Physiomics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:18 41,584 @ 1.20p
16:16 62,500 @ 1.20p
15:05 15,094 @ 1.33p
14:44 2,285 @ 1.20p
13:21 53,219 @ 1.23p

Physiomics Key Personnel

COO Christophe Chassagnole
CEO Peter Sargent

Top of Page